| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01994291 2013-003147-27 Details | 2016-10-17 Interventional | 2 | 199 | Ranibizumab Edema Macular Edema Macular Edema, … | - - | |||
| NCT01068756 Details | 2016-10-17 Interventional | 1 | 14 | Dapagliflozin Rifampin Diabetes Mellit… Type 2 Diabetes… | - - | |||
| NCT00726505 Details | 2016-10-17 Interventional | 1 | 1 | Dapagliflozin Diabetes, NOS | - - | |||
| NCT01661140 2011-005260-20 Details | 2016-10-14 Interventional | 4 | 427 | Methotrexate Arthritis Arthritis, Rheu… Rheumatoid Arth… | - - | |||
| NCT01050426 Details | 2016-10-14 Interventional | 2 | 17 | Cetuximab Leucovorin Levoleucovorin Pancreatic Neop… Pancreatic Canc… | Data from other trials failed to demonstrate meaningful survival advantage - | |||
| NCT00788606 Details | 2016-10-14 Interventional | 2 | 7 | Bevacizumab Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, Large… Lymphoma, Non-H… B-cell Lymphoma Non-Hodgkin's L… | Toxicity and efficacy data from another trial - | |||
| NCT02485080 Details | 2016-10-13 Interventional | 4 | 0 | Simeprevir Sofosbuvir Hepatitis Hepatitis C Hepatitis C, Ch… PT-NANBH | Withdrawn due to lack of resources - | |||
| NCT01123473 2009-011580-36 Details | 2016-10-12 Interventional | 2 | [1 Refs] | 29 | Capecitabine Epirubicin Fluorouracil Lapatinib Adenocarcinoma Esophageal Neop… Stomach Neoplas… Adenocarcinoma … Gastric Cancer | company withdrew interest - | ||
| NCT02376972 Details | 2016-10-10 Interventional | 2 | 392 | Metronidazole Rifaximin Vaginal Disease… Vaginosis, Bact… BACTERIAL VAGIN… | According to the Recommendation of the Indipendent Data Monitoring Committee - | |||
| NCT00597116 2007-003633-16 Details | 2016-10-10 Interventional | 2 | 25 | Vinorelbine Mesothelioma Mesothelioma, M… | Recruitment stopped according to early stopping rule (by protocol) Early termination leading to small number of subjects analyzed. | |||
| NCT02605356 2015-000427-82 Details | 2016-10-07 Interventional | 1/2 | 0 | Bortezomib Dexamethasone Radium Ra 223 d… Multiple Myelom… Neoplasms, Plas… | Study restarted under new study number 18987 - | |||
| NCT01405742 Details | 2016-10-07 Interventional | 3 | 4 | Factor VIII Hemophilia A Severe Hemophil… | study was non-feasible per DSMB - | |||
| NCT00912899 Details | 2016-10-07 Interventional | 1 | 12 | Noscapine Multiple Myelom… Neoplasms, Plas… Refractory Mult… | Terminated early due to lack of clinical response. - | |||
| NCT00316680 Details | 2016-10-07 Interventional | 3 | - | Vaccines Diphtheria Hepatitis Hepatitis A Hepatitis B Haemophilus Inf… Tetanus Whole Cell Pert… | - - | |||
| NCT02380313 Details | 2016-10-06 Interventional | 1 | 0 | Prednisone Cancer | Study cancelled: Withdrawn before enrollment of any participants - | |||
| NCT01039103 2009-013884-21 Details | 2016-10-06 Interventional | 2 | 15 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Multiple Sclero… Multiple Sclero… Sclerosis Syndrome Acute Exacerbat… Clinically Isol… | - - | |||
| NCT02263677 Details | 2016-10-05 Interventional | 4 | 0 | Sitagliptin Pho… Fatty Liver Liver Diseases Non-alcoholic F… Type 2 Diabetes | Technical difficulties have caused this study to be terminated - | |||
| NCT02201524 Details | 2016-10-05 Interventional | 2 | 59 | Abrocitinib Psoriasis Plaque Psoriasi… | Study terminated 26 June 2015 due to changes in the drug development portfolio. This study was
not terminated for reasons of safety and/or efficacy The study was terminated early due to changes in the prioritization of the drug development portfolio and the early termination was not safety related. | |||
| NCT00956709 Details | 2016-10-05 Interventional | 4 | 35 | Levobupivacaine Ropivacaine Nerve Block | - - | |||
| NCT01219062 Details | 2016-10-04 Interventional | 4 | 10 | Bupivacaine Morphine Femoral Neck Fr… Pain, Postopera… Femoral Neck Fr… | Surgeon team were not happy with the study protocol, the periarticular injection of local
anesthetics - |